SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 286.88 |
| Enterprise Value ($M) | 436.49 |
| Book Value ($M) | 191.88 |
| Book Value / Share | 9.07 |
| Price / Book | 1.50 |
| NCAV ($M) | 153.69 |
| NCAV / Share | 7.26 |
| Price / NCAV | 1.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.34 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.25 |
| Current Ratio | 6.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 390.30 |
| Assets | 428.50 |
| Liabilities | 236.62 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 79.20 |
| Operating Income | -137.21 |
| Net Income | -133.82 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -103.15 |
| Cash from Investing | -53.58 |
| Cash from Financing | 198.13 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.80 | -0.67 | |
| 13G/A | Vanguard Group Inc | 8.52 | 17.84 | |
| 13G/A | Farallon Capital Partners, L.P. | 9.60 | 30.65 | |
| 13G/A | BlackRock Inc. | 9.20 | -2.19 | |
| 13G/A | State Street Corp | 2.02 | -71.85 | |
| 13G | Millennium Management Llc | 6.20 | 28.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 11,829 | 57,755 | 20.48 | |
| 21,730 | 123,263 | 17.63 | |
| 12,625 | 90,159 | 14.00 | |
| 16,608 | 29,141 | 56.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EDIT – Editas Medicine, Inc. | ELEV – Elevation Oncology, Inc. |
| ELVN – Enliven Therapeutics, Inc. | ERAS – Erasca, Inc. |
| EWTX – Edgewise Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io